Roanoke-based Chorda Pharma moves toward product release with grant Gene Marrano June 27, 2022 1 minute read Chorda Pharma, a local pharmaceutical company looking to bring its first product, Capsadyn – an over the counter medication for chronic pain to market next year – has received an important grant from the Commonwealth Commercialization Fund. Share: Post navigation Previous: Congressman Bob Good pushes Life at Conception ActNext: Late on returning library books? That’s no longer a problem Related Stories Baby Buri author brings her illustrated books to Roanoke Gene Marrano June 9, 2026 VA250 close to home – In Depth. Who was Andrew Lewis? Gene Marrano June 9, 2026 Virginia Tech secures record $75 million gift for athletics and academics Web Staff June 8, 2026